ASCO 2023: Precigen reports positive early data for CAR-T therapy

cafead

Administrator
Staff member
  • cafead   Jun 06, 2023 at 11:22: AM
via New early data suggests Precigen Therapeutics’s CAR-T therapy PRGN-3005 could decrease tumour burden in advanced ovarian cancer.

article source
 

<